Stock ZVSA ZYVERSA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders ZyVersa Therapeutics, Inc.

Equities

ZVSA

US98987D3008

Market Closed - Nasdaq
Other stock markets
 04:30:01 2024-05-28 pm EDT 		5-day change 1st Jan Change
4.254 USD -1.31% Intraday chart for ZyVersa Therapeutics, Inc. -3.33% -52.74%
Mar. 25 ZyVersa Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 18 ZyVersa Therapeutics, Inc. Announces IRB Approval of Phase 2A Clinical Trial Protocol to Evaluate Cholesterol Efflux Mediator VAR 200 in Patients with Diabetic Kidney Disease CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
ZyVersa Therapeutics, Inc. Announces Board Changes
CI
ZyVersa Therapeutics, Inc. Announces Changes to Board of Directors
CI
Zyversa Therapeutics Announces That Richard J. Glassock Has Joined Zyversa’a Renal Scientific Advisory Board
CI
ZyVersa Therapeutics Reports Inducement Grant to Newly Appointed Chief Medical Officer Under Nasdaq Listing Rule 5635(c)(4)
GL
ZyVersa Therapeutics, Inc. Appoints Dr. Pablo Guzman as Chief Medical Officer and Senior Vice President of Medical Affairs
CI
ZyVersa Therapeutics, Inc. Announces Executive Changes
CI
ZyVersa Therapeutics, Inc. Adds Two Esteemed Leaders to Its Renal Scientific Advisory Board
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ZVSA Stock
  4. News ZyVersa Therapeutics, Inc.
  5. Insiders